SCHEMBL12008525

SCHEMBL12008525

CCOc1cc(/C=C2\SC(=S)N(CCCC(=O)O)C2=O)ccc1OCc1ccccc1Cl

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 4/20 0.70
▸ PSMD14 O00487 1/20 0.70
▸ PLEC Q15149 1/20 0.70
▸ KMT2A Q03164 4/20 0.65
▸ ADAMTS5 Q9UNA0 2/20 0.65
▸ APAF1 O14727 1/20 0.65
▸ CTNNB1 P35222 2/20 0.63
▸ TCF4 P15884 1/20 0.63
▸ DVL1 O14640 1/20 0.62
▸ FABP4 P15090 1/20 0.61
▸ MEN1 O00255 3/20 0.57
▸ DNMT1 P26358 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ GAA P10253 1/20 0.55
▸ AKR1B1 P15121 1/20 0.55
▸ PTPN1 P18031 1/20 0.55
▸ MAPT P10636 2/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ RECQL P46063 1/20 0.54
▸ MITF O75030 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12008509 0.95 KMT2A (0.72) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL12008523 0.93 CTNNB1 (0.75) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL12008511 0.89 CTNNB1 (0.78) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL12008507 0.88 KMT2A (0.71) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL13446857 0.87 POLB (0.74) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL12008521 0.85 AKR1B1 (0.67) POLBPSMD14PLECKMT2ACTNNB1
SCHEMBL12008552 0.85 CTNNB1 (0.87) POLBPSMD14PLECKMT2ACTNNB1
SCHEMBL13446890 0.85 CTNNB1 (0.87) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL12008549 0.84 FABP4 (0.85) POLBPSMD14PLECKMT2AADAMTS5
SCHEMBL12008625 0.83 CTNNB1 (0.69) POLBPSMD14PLECKMT2AADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 POLB 2397/4885PSMD14 1726/4885PLEC 1948/4885
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof CTNNB1, CTNNA1, CTNNBL1 POLB 2088/4885PSMD14 1902/4885PLEC 2097/4885
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 POLB 2088/4885PSMD14 1902/4885PLEC 2097/4885
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 POLB 2088/4885PSMD14 1902/4885PLEC 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback